B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5
B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lowers the price target from $2 to $1.5.
Stocks · News reference
8-K/A filing — biote Corp. (BTMD)
Filed: 2026-06-17 AccNo: 0001193125-26-274137 Size: 147 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2
TD Cowen analyst Jonna Kim maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $2.5 to $2.
Biote shares are trading lower after the company reported worse-than-expected Q2 financial results.
Biote FY2026 Revenue expected to be more than $175.000M vs $190.807M Est
Biote (NASDAQ:BTMD) FY2026 Revenue expected to be more than $175.000M vs $190.807M Est